Delayed defibrillation testing after CRT-D implant-weighing competing risks

Journal of Cardiovascular Electrophysiology

Volumn 16, Issue 12, 2005, Pages 1284-1285

  Saxon, Leslie ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Cardiac Electrophysiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATION; DEFIBRILLATOR; EDITORIAL; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE FIBRILLATION; HEMODYNAMICS; HUMAN; IMPLANTATION; MORBIDITY; MORTALITY; PATIENT SAFETY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SYMPTOMATOLOGY; CARDIOVERSION; HEART PACING; INSTRUMENTATION; NOTE; RISK ASSESSMENT; RISK FACTOR; SAFETY; TIME;

CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; RISK ASSESSMENT; RISK FACTORS; SAFETY; TIME FACTORS;

EID: 33644863004     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2005.00275.x     Document Type: Editorial

References (12)

1. Gasparini M Galimberti P Regoli F Ceriotti C Bonadies M: Delayed defibrillation testing in patients implanted with biventricular ICD (CRT-D): A reliable and safe approach. J Cardiovasc Electrophysiol 2005 xx: xxx xxx.
2. Decision Memo for Implantable Defibrillators ( CAG-00157R3). Available at: http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=148.
3. Strickberger SA Klein GJ: Is defibrillation testing required for defibrillator implantation? J Am Coll Cardiol 2004 44: 88 91.
4. Higgins SL Hummel JD Niazi IK Giudici MC Worley SJ Saxon LA Boehmer JP Higginbotham MB De Marco T Foster E Yong PG: Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003 42: 1454 1459.
5. Young JB Abraham WT Smith AL Leon AR Lieberman R Wilkoff B Canby RC Schroeder JS Liem LB Hall S Wheelan K, for the Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators: Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003 289: 2685 2694.
6. Bristow MR Saxon LA Boehmer J Krueger S Kass DA De Marco T Carson P DiCarlo L DeMets D White BG DeVries DW Feldman AM, for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350: 2140 2150.
7. Tokano T Bach D Chang J Davis J Souza JJ Zivin A Knight BP Goyal R Man KC Morady F Strickberger SA: Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol 1998 9: 791 797.
8. Schluter T Baum H Plewan A Neumeier D: Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage. Clin Chem 2001 47: 459 463.
9. Saxon LA Bristow MR DeMarco T Krueger SK: Procedural outcomes and device performance in the COMPANION Trial of resynchronization therapy for heart failure. Circulation 2004 110: III 443.
10. Bardy GH Lee KL Mark DB Poole JE Packer DL Boineau R Domanski M Troutman C Anderson J Johnson G McNulty SE Clapp-Channing N Davidson-Ray LD Fraulo ES Fishbein DP Luceri RM Ip JH, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure. N Engl J Med 2005 352: 225 237.
11. Whang W Mittleman MA Rich DQ Wang PJ Ruskin JN Tofler GH Muller JE Albert CM, for the TOVA Investigators: Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: Results from the Triggers Of Ventricular Arrhythmias (TOVA) Study. Circulation 2004 109: 1386 1391.
12. Wilkoff BL Hess M Young J Abraham WT: Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 2004 15: 1002 1009.